During acute infection with bacteria, viruses or parasites, a fraction of macrophages engulf large numbers of red and white blood cells, a process called hemophagocytosis. Hemophagocytes persist into the chronic stage of infection and have an anti-inflammatory phenotype. Salmonella enterica serovar Typhimurium infection of immunocompetent mice results in acute followed by chronic infection, with the accumulation of hemophagocytes. The mechanism(s) that triggers a macrophage to become hemophagocytic is unknown, but it has been reported that the proinflammatory cytokine gamma interferon (IFN-␥) is responsible. We show that primary macrophages become hemophagocytic in the absence or presence of IFN-␥ upon infection with Gram-negative bacterial pathogens or prolonged exposure to heat-killed Salmonella enterica, the Gram-positive bacterium Bacillus subtilis, or Mycobacterium marinum. Moreover, conserved microbe-associated molecular patterns are sufficient to stimulate macrophages to hemophagocytose. Purified bacterial lipopolysaccharide (LPS) induced hemophagocytosis in resting and IFN-␥-pretreated macrophages, whereas lipoteichoic acid and synthetic unmethylated deoxycytidine-deoxyguanosine dinucleotides, which mimic bacterial DNA, induced hemophagocytosis only in IFN-␥-pretreated macrophages. Chemical inhibition or genetic deletion of Toll-like receptor 4, a pattern recognition receptor responsive to LPS, prevented both Salmonella-and LPS-stimulated hemophagocytosis. Inhibition of NF-B also prevented hemophagocytosis. These results indicate that recognition of microbial products by Toll-like receptors stimulates hemophagocytosis, a novel outcome of prolonged Toll-like receptor signaling, suggesting hemophagocytosis is a highly conserved innate immune response.
C
hronic infections cause significant damage to the host. Therefore, the host must balance tissue damage and pathogen load. In the early 1970s, plant biologists coined the term "tolerance," the endurance of a severe disease without loss in yield or quality (1, 2) . This concept has recently been applied to mammalian-pathogen interactions, whereby disease tolerance enables a host to survive infection by reducing or limiting disease severity without eliminating the pathogen (3) .
Toll-like receptors (TLRs) are pattern recognition receptors expressed by many kinds of cells. TLRs recognize structurally conserved microbial ligands, such as bacterial cell wall components, bacterial DNA, and viral RNA. Macrophages become microbicidal when TLRs bind to these or other microbial associated molecular patterns (MAMPs). TLR activation also stimulates macrophage secretion of proinflammatory cytokines and production of danger-associated molecules such as HMGB1. Left unchecked, inflammation causes significant host damage. However, macrophages have the potential to tip the balance in favor of tolerance; these same cells produce anti-inflammatory cytokines and also products that heal wounds and repair tissue (4) . TLR activation contributes to the transition from inflammatory to regulatory macrophage. For instance, TLR followed by CD39 activation results in macrophage anti-inflammatory cytokine production (5) , and TLR signaling leads to the production of miRNAs that negatively regulate TLRs (6) .
Hemophagocytes are a specialized class of macrophage that have engulfed platelets, erythrocytes and leukocytes. Hemophagocytes express anti-inflammatory markers and accumulate in patients with severe systemic infections with pathogens such as Salmonella enterica, Mycobacterium tuberculosis, Epstein-Barr and mumps viruses, and species of the malarial parasite Plasmodium (7) . Hemophagocyte accumulation is also associated with inflammatory diseases, including sepsis, hemophagocytic lymphohistiocytosis (HLH), macrophage activation syndrome, and systemic inflammatory response syndrome (8) . Although hemophagocytes from human typhoid victims were described over a century ago (9, 10) , these cells remain poorly understood.
Hemophagocytes have been studied in several different mouse models of HLH, a human disease syndrome triggered by infection and characterized by fever, splenomegaly, cytopenias, hemophagocytosis in bone marrow and spleen, hyperferritinemia, and hypofibrinogenemia (7, 11) . For example, mice deficient for perforin 1 and infected with lymphocytic choriomeningitis virus develop HLH, including hemophagocyte accumulation in the spleen and bone marrow (12) . Hemophagocytes also accumulate in immunodeficient, humanized mice infected with Epstein-Barr virus (13) . In addition, delivery of gamma interferon (IFN-␥) to the intraperitoneal cavity of wild-type mice results in hemophagocyte accumulation in the spleen (14) , leading to the suggestion that IFN-␥ stimulates hemophagocytosis (7, (13) (14) (15) (16) (17) .
We study hemophagocytes in a natural host-pathogen relationship using immunocompetent (SV129S6) mice and the bac-terium S. enterica serotype Typhimurium (18) . S. Typhimurium infection of mice via an oral route elicits monocyte infiltration into the small intestine. Monocytes engulf the bacterium and deliver it to the lymph nodes that drain the intestine, the spleen, and the liver, where S. Typhimurium survives within macrophages (19) . Macrophages that harbor the bacteria include hemophagocytic macrophages, which accumulate in the liver and spleen as early as 1 week after inoculation (20, 21) . During the acute stage of infection, these mice develop clinical signs consistent with human HLH, in addition to modeling human typhoid fever (18, 19, 22) . Approximately 3 to 5% of total splenic macrophages are hemophagocytic at 4 weeks postinoculation, based on increased DNA content (flow cytometric analysis of DAPI [4=,6=-diamidino-2-phenylindole]-stained macrophages) (21) . Confocal microscopy has identified S. Typhimurium within hemophagocytes in the liver from 1 to 8 weeks postinfection (20) . These cells may be a survival niche for S. Typhimurium because they provide the bacteria with iron (23) . In addition, hemophagocytes appear to have an alternatively activated phenotype (7, 21, 24) , suggesting that they are less adept at killing pathogens than other kinds of macrophages (25) .
We recently reported that in cell culture, treatment with IFN-␥ is not sufficient to drive macrophages to hemophagocytose (26) . Here, we address the molecular events behind bacterium-driven hemophagocytosis. We found that infection with either S. Typhimurium or another virulent Enterobacteriaceae family member, Yersinia pseudotuberculosis, stimulated hemophagocytosis. Moreover, prolonged exposure to heat-killed bacteria from diverse phyla, or to purified MAMPs was sufficient to promote hemophagocytosis. Inhibition of TLR4 activation prevented lipopolysaccharide (LPS) from stimulating hemophagocytosis. These observations indicate that hemophagocytosis is an evolutionarily conserved response to microbial products and potentially outline a role for hemophagocytes in disease tolerance.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Salmonella enterica subsp. enterica serovar Typhimurium wild-type strain SL1344 was transformed with pRFPTag (ESH829, Fig. 1, 2 , and 4) (26) or transduced with green fluorescent protein (GFP) and a kanamycin resistance cassette at sifB (sifB::GFP-Kan STm, CSD1021) (27) . S. Typhimurium was grown overnight at 37°C in Luria-Bertani broth with aeration. Antibiotics were used at the following concentrations: streptomycin, 30 g/ml; ampicillin, 300 g/ml; and kanamycin, 30 g/ml. There were no significant differences in the fractions of hemophagocytes formed or in the TER119 median fluorescence intensity (MFI) of hemophagocytes after infection with ESH829 or CSD1021 (P Ͼ 0.05). Y. pseudotuberculosis strain IP2666 was grown overnight at 26°C in Luria-Bertani broth with aeration and plated to irgasan (2 g/ml) (28) .
BMDM generation. Research protocols were approved by the University of Colorado Institutional Committee for Animal Care and Use. Bone marrow-derived macrophages (BMDMs) were derived using 30% 3T3-MCSF cell-conditioned supernatant as previously described (26) . Briefly, marrow was flushed from the femurs and tibias of 2-to 4-month-old 129SvEvTac mice from Taconic Laboratories or C3H/HEJ (TLR4 Ϫ/Ϫ ) or C3H/HeOuJ (TLR4 ϩ/ϩ ) mice from Jackson Laboratories. Cells were resuspended in 1ϫ phosphate-buffered saline (PBS) and penicillin-streptomycin (penicillin, 50 IU/ml; streptomycin, 50 g/ml). Cells were overlaid onto an equal volume of Histopaque-1083 (Sigma-Aldrich) and centrifuged at 500 ϫ g for 20 min. Monocytes at the interface were harvested, washed twice in 1ϫ PBS and penicillin-streptomycin, and resuspended in Dulbecco modified Eagle medium (DMEM; Sigma-Aldrich) supplemented with fetal bovine serum (10%), L-glutamine (2 mM), sodium pyruvate (1 mM), ␤-mercaptoethanol (50 M), HEPES (10 mM), and penicillin-streptomycin. These cells were seeded at 3 ϫ 10 5 /well in DMEM supplemented with 30% macrophage colony-stimulating factor and incubated at 37°C in 5% CO 2 . On day 3, the medium was refreshed. Cells were used on day 7.
BMDM uptake of erythrocytes. BMDMs were isolated as described above and were seeded at 3 ϫ 10 5 cells per well in a six-well plate. Where indicated, the BMDMs were pretreated with 20 U of IFN-␥/ml for 18 to 24 h prior to the addition of erythrocytes, bacteria, and/or purified bacterial molecules. Murine erythrocytes were freshly isolated by cardiac puncture, harvested by centrifugation for 10 min, and added to BMDMs at a 1:1 or 10:1 erythrocyte/BMDM ratio. At the higher ratio, more hemophagocytes were typically observed. For the studies on purified bacterial molecules, LPS (Sigma-Aldrich) was added at 20, 2, or 0.2 ng/ml, lipoteichoic acid (LTA; Sigma-Aldrich) was added at 0.01 mg/ml, CpG (InvivoGen) was added at 1 M, poly(I·C) (a gift from H. Yin) was added at 10 or 25 g/ml (data not shown), and flagellin (Sigma-Aldrich) was added at 0.05 g/ml. For addition to BMDMs, bacterial molecules or heat-killed bacteria were resuspended to their final concentration in complete DMEM supplemented with gentamicin (10 g/ml), along with the appropriate concentration of erythrocytes. For infection with live S. Typhimurium, macrophages were washed 30 min after infection and incubated for 1.5 h at 37°C in fresh medium supplemented with gentamicin (100 g/ml) to kill extracellular bacteria. Medium was then exchanged for medium supplemented with gentamicin (10 g/ml) to prevent extracellular bacterial growth, and erythrocytes were resupplied at the same concentration after each medium change (26) . For the studies on TLR4 inhibition, BMDMs were pretreated with 1, 2.5, or 5 M TAK242 (Invivogen) or vehicle (DMSO) control for 60 to 90 min before the addition of LPS (20 ng/ml) or infection with live S. Typhimurium. The infection studies in the presence of TAK242 were carried out as described above, except that erythrocytes were added when 10 g of gentamicin/ml was added. There were no differences in the fractions of hemophagocytes formed if erythrocytes were added at each medium change or only to the final medium change (data not shown). To control for changes in erythrocytes during storage at 37°C with 5% CO 2 for up to 8 h, a parallel set of BMDMs remained unexposed to LPS and were incubated with stored erythrocytes. By 18 h, the fraction of hemophagocytes did not differ from BMDMs exposed to fresh erythrocytes.
Flow cytometry. Samples were processed for intracellular flow cytometry as previously described (26) . BMDMs were Fc blocked with anti-CD16/32 (eBioscience) and stained with Live/Dead Near-IR stain (Life Technologies) at 1:3,000 and with TER119-APC (eBioscience) at 1:200. Fluorescently labeled cells were analyzed using a CyAn ADP flow cytometer (Beckman Coulter) and FlowJo software version 8.8.7 (Tree Star, Inc.). A minimum of 10,000 live cells were collected for analysis. In all experiments, hemophagocytes had similar TER119 MFI values; there were no statistically significant MFI differences within experiments. The MFI was normalized by subtracting background fluorescence from the APC channel.
Statistics. Data were analyzed using JMP Pro version 11.2.0. (SAS Institute, Inc.). Two-way comparisons were analyzed with a Student t test (for parametric data). Multiple comparisons were analyzed by analysis of variance (ANOVA) with a Tukey's (parametric data) or Dunnett's (nonparametric data) post hoc test.
RESULTS
Prolonged macrophage exposure to dead or heat-killed S. Typhimurium stimulates hemophagocytosis. Infection of macrophages with S. Typhimurium, but not with E. coli, stimulates hemophagocytosis (26) . However, the E. coli strain tested was a laboratory strain that macrophages kill within 2 h (29). To establish whether hemophagocytosis is stimulated by another Enterobacteriaceae family member that survives within macrophages, we tested Yersinia pseudotuberculosis strain IP2666 (28) . Hemophagocytosis was monitored by intracellular flow cytometry; macrophages that have engulfed erythrocytes stain positive for the erythrocyte marker TER119 (see Fig. S1 in the supplemental material) (23) . At 18 h after infection with either bacterium, ca. 7% of resting macrophages engulfed erythrocytes, compared to Ͻ1% of macrophages incubated without bacteria (Fig. 1A) . Intracellular bacterial survival did not differ significantly (Fig. 1B) . Thus, infection by either S. Typhimurium or Y. pseudotuberculosis stimulates macrophages to hemophagocytose.
Y. pseudotuberculosis and S. Typhimurium use different strategies to cause disease. However, since both are capable of survival within macrophages, we hypothesized that prolonged exposure to bacteria is key to stimulating hemophagocytosis. Infection of macrophages with live S. Typhimurium was compared to continuous exposure to heat-killed S. Typhimurium over 18 h, and both conditions stimulated significant hemophagocytosis (Fig. 1C to  F) . IFN-␥ pretreatment alone does not appear to enhance erythrocyte uptake. Thus, prolonged exposure, i.e., Ն12 h, to either live or dead bacteria stimulates hemophagocytosis.
The fraction of macrophages that hemophagocytose saturates with increasing infectious dose. We then exposed resting and IFN-␥-pretreated macrophages to a 10-fold dilution series of S. Typhimurium to establish whether hemophagocytosis is responsive to bacterial dose. At a multiplicity of infection (MOI) of 100, the macrophage monolayer was largely destroyed within 18 h, and therefore no other data were collected. In the remaining samples, hemophagocytosis and infection were monitored by flow cytometry. The percentage of resting or IFN-␥-pretreated macrophages that became hemophagocytic increased and then leveled off at an MOI of 1.0, at approximately 10 to 15% of the total macrophages. This observation suggests that only a fraction of macrophages have the capacity to hemophagocytose under these conditions ( Fig. 2A and F) . In contrast, the percentage of macrophages that became infected and the total CFU both rose with increasing MOI (Fig. 2B, G, E, and J) . At 18 h postinfection, nonhemophagocytes were as likely as hemophagocytes to be infected at all bacterial dosages tested (Fig. 2C, D, H, and I) , a finding consistent with engulfment of erythrocytes after infection (Fig. 1) . Altogether, bacterium-driven hemophagocytosis appears to be Evolutionarily diverse bacteria stimulate hemophagocytosis and reveal differences between resting and IFN-␥-treated macrophages. To establish whether bacteria outside the Enterobacteriaceae family stimulate hemophagocytosis, we tested heat-killed Bacillus subtilis (a representative Gram-positive bacterium) and Mycobacterium marinum. In both resting and IFN-␥-pretreated macrophages, heat-killed Gram-negative bacterial species promoted the largest fraction of macrophages to hemophagocytose, followed by M. marinum (Fig. 3) . Heat-killed B. subtilis stimulated hemophagocytosis only in the IFN-␥-pretreated macrophages. The stimulation of hemophagocytosis by bacteria from distinct phyla mirrors observations in humans with severe infections caused by diverse pathogens (30) . TLR4, TLR2, or TLR9 agonists induce hemophagocytosis. TLRs are key macrophage receptors for recognition of bacterial ligands. We hypothesized that whole heat-killed bacteria induced hemophagocytosis via TLR activation and that a single MAMP is sufficient. Macrophages were exposed to increasing doses of purified S. Typhimurium LPS, which activates TLR4 (31) . LPS induced hemophagocytosis in a dose-dependent manner in resting and IFN-␥-pretreated macrophages ( Fig. 4A and B) . To determine whether the duration of macrophage exposure to LPS affects whether or not hemophagocytosis occurs, we incubated macrophages with LPS and erythrocytes for 2, 4, 8, or 18 h. At the end of each interval, macrophages were washed and then reexposed to only erythrocytes for the remainder of the experiment, and hemophagocytes were quantified by flow cytometry at 18 h. The percentage of hemophagocytes increased with the length of exposure to LPS, particularly in IFN-␥-pretreated macrophages ( Fig.  4C and D) . Thus, 2 h of exposure to purified LPS induces hemophagocytosis in IFN-␥-pretreated macrophages, but longer exposure times are needed for resting macrophages.
We also examined purified LTA from Staphylococcus aureus (a TLR2 agonist), class B CpG oligodeoxynucleotide (a TLR9 agonist), poly(I·C) (a TLR3 agonist), and purified S. Typhimurium flagellin (a TLR5 agonist) for their ability to stimulate hemophagocytosis. Each agonist was tested at concentrations known to stimulate TLRs on macrophages (32-36). Flagellin did not stimulate hemophagocytosis, which is consistent with the lack of TLR5 activity in murine macrophages (37) . Poly(I·C) also did 
macrophages (hemophagocytes). (B and G) Mean percentage of GFP-expressing STm-infected macrophages. (C and H) Mean percentage of GFP-expressing STm-infected hemophagocytes (out of total hemophagocytes). (D and I) Mean percentage of GFP-expressing STm-infected nonhemophagocytes (out of total nonhemophagocytes). (E and J) CFU/well.
Means Ϯ the SEM of aggregated data were determined from three biological replicates. P values were determined by ANOVA with a Dunnett's posttest. *, P Յ 0.05; **, P Յ 0.0001 (compared to no bacteria). #, P Յ 0.05; ##, P Յ 0.0001 (compared to an MOI of 10).
FIG 3
Prolonged macrophage exposure to HK bacteria from different phyla stimulates hemophagocytosis. Resting (A) or IFN-␥-pretreated (B) macrophages were cocultured with erythrocytes at a ratio of 1:10 without bacteria or with HK bacteria (MOI of 10). After 18 h, macrophages were processed for flow cytometry. Means Ϯ the SEM of aggregated data were determined from three biological replicates. P values were determined by ANOVA with a Dunnett's posttest. *, P Յ 0.05; **, P Յ 0.0001 (compared to no bacteria). ns, not significant (compared to no bacteria). not stimulate hemophagocytosis despite reported TLR3 expression by mouse macrophages (38) . However, prolonged exposure to LTA or CpG significantly increased the fraction of hemophagocytes, but only in IFN-␥-pretreated macrophages (Fig. 4E and F) . These data are consistent with observed increases in expression of TLRs in IFN-␥-pretreated, compared to resting, macrophages (32, 39) . Thus, macrophages may be more likely to hemophagocytose as acute infection develops and proinflammatory cytokines stimulate increased TLR expression.
TLR4 signaling through NF-B induces hemophagocytosis. We used chemical and genetic approaches to establish whether LPS and/or S. Typhimurium induces macrophage hemophagocytosis via TLR4. Macrophages were treated with a chemical inhibitor of TLR4 signaling, TAK242, which binds the intercellular domain of TLR4 and blocks association with the TIRAP and TRAM adaptor proteins, effectively preventing MyD88-dependent and MyD88-independent signaling (40) . In both resting and IFN-␥-pretreated macrophages, treatment with TAK242 inhibited LPSand bacterium-induced hemophagocytosis (Fig. 5 and 6A and C).
TAK242 did not affect the percentage of infected macrophages ( Fig. 6G and J) but significantly increased bacterial survival in IFN-␥-pretreated macrophages ( Fig. 6B and D) . To confirm a role for TLR4 in hemophagocyte formation, we compared TLR4 ϩ/ϩ and TLR4 Ϫ/Ϫ macrophages; LPS treatment or infection with live S. Typhimurium stimulated hemophagocyte formation only in the presence of TLR4. The percentages of S. Typhimurium-infected hemophagocytes were similar (Fig. 7) . Thus, TLR4 is required for hemophagocytosis in response to LPS or S. Typhimurium, and LPS appears to be the major constituent of S. Typhimurium that stimulates hemophagocytosis.
TLR4 signaling activates the transcription factors NF-B and IRF3/7. BMS-345541 is a specific inhibitor of the IKK kinase complex, which sequesters NF-B in the cytoplasm (41) . Treatment of macrophages with BMS-345541 prevented LPS-induced hemophagocytosis (Fig. 8) , suggesting that activation of NF-B is needed to reprogram macrophages to hemophagocytose.
DISCUSSION
Our results show that macrophages are induced to hemophagocytose after incubation with pathogenic S. Typhimurium or Y. pseudotuberculosis, or upon exposure to heat-killed bacteria from different phyla. The failure of infection with live, nonpathogenic E. coli to induce hemophagocytosis (26) likely reflects that laboratory strains are killed and digested by macrophages within 2 h of their addition and that the E. coli that remained extracellular was washed away (29) . In contrast, prolonged exposure to HK E. coli may provide sufficient sustained TLR4 stimulation to induce hemophagocytosis. Prolonged exposure to purified MAMPs also promoted hemophagocytosis, increasing the fraction of hemophagocytes by 5-to 20-fold over that observed in the absence of bacteria. The concentrations of MAMPs needed to induce hemophagocytosis are consistent with those that stimulate TLR signaling (31) (32) (33) (34) . In resting macrophages, LPS and Gram-negative bacteria were more potent stimulators of hemophagocytosis than LTA or Gram-positive bacteria, which is consistent with reports of TLR4 expression by resting macrophages and TLR2 and TLR4 induction upon macrophage activation (39, 42) . LPS-and S. Typhimurium-induced hemophagocytosis requires TLR4, indicating a novel role for TLR signaling in the reprogramming of macrophages to hemophagocytose. (E and F) 0.01 mg/ml LTA, 1 M CpG, 10 g/ml poly(I·C), or 0.05 g/ml flagellin. Means Ϯ the SEM of aggregated data were determined from three biological replicates. P values were determined by ANOVA with a Tukey's (A and C) or Dunnett's (B, D, E, and F) posttest. *, P Ͻ 0.05; **, P Ͻ 0.0001 (compared to 0 ng/ml LPS or 0 h of LPS exposure time). #, P Յ 0.05 (compared to 0.2 ng/ml LPS). For panels A and E and panels B and F, the 0-ng/ml and 0-h data are from the same experiment. ns, not significant (compared to no agonist). TLR signaling is transmitted through adaptor proteins, and those that signal through MyD88 may be needed to drive hemophagocytosis. TLR4, TLR2, and TLR9 all stimulate NF-B through MyD88, whereas TLR3 signaling is MyD88 independent (43) , and a TLR3 agonist did not promote hemophagocytosis. NF-B activates some downstream targets within minutes and other targets within hours. For example, in cultured monocytes and macrophages, HMGB1 does not accumulate in the cytoplasm or in the serum for 4 to 18 h after stimulation with LPS (44) (45) (46) . Likewise, NF-B-induced mRNA for IL-12p40 and TNF-␣ increases within 4 h, but the corresponding proteins require 4 to 16 h to accumulate (5, 47) . NF-B also regulates miRNAs, the effects of which are complex and may require hours (48) . In other words, the requirement for prolonged macrophage exposure to microbial stimuli may reflect the involvement of an NF-B target that is not rapidly activated.
Hemophagocytosis driven by TLR activation in cell culture is consistent with reports demonstrating stimulation of hemophagocytosis in vivo following systemic delivery of TLR agonists in murine models (7) . For example, a single intravenous dose of CpG (200 g) stimulates hemophagocytosis, and intraperitoneal delivery of 5 ϫ 10 8 CFU heat-killed Brucella abortus stimulates splenic macrophages to bind and engulf erythrocytes (49, 50) . In humans and mice, hemophagocytic diseases correlate with high serum proinflammatory cytokines and, in mice, repeated delivery of IFN-␥ to the peritoneal cavity in the absence of an infectious agent is sufficient to promote hemophagocytosis in the spleen (14, 30) . It has been therefore suggested that IFN-␥ drives hemophagocytosis (7, (15) (16) (17) . However, IFN-␥ is not required for hemophagocytes to accumulate in mice or in culture (26, 51) . TLR and IFN-␥ signaling activate different transcription factors, NF-B and IRFs versus STAT1, respectively. In addition, IFN-␥ increases expression of pathogen recognition receptors, including TLRs, and decreases the threshold concentration of MAMPs required to stimulate TLRs and induce cytokines and microbicidal activities (52, 53) . We postulate that IFN-␥ indirectly stimulates hemophagocy- . After 1 h, the macrophages were cocultured with erythrocytes at a ratio of 1:10, and LPS (20 ng/ml) was added. After 18 h, the macrophages were processed for flow cytometry. Means Ϯ the SEM of aggregated data were determined from at least three biological replicates. P values were determined by ANOVA with a Dunnett's posttest. *, P Յ 0.05 (compared to vehicle). (C) Predicted pathway of TLR4-induced hemophagocytosis, including the point-of-action of inhibitors used in the present study. tosis when delivered systemically to mice. IFN-␥ activates neutrophils (54, 55) , which cause bystander tissue damage and the release of danger-associated molecular patterns (DAMPs). DAMPs in turn activate TLRs (56) and may thereby drive macrophages to hemophagocytose, even in the absence of infection. Thus, TLR activation via DAMPs may explain why exogenous cytokines are sufficient to drive hemophagocytosis in vivo. Whether hemophagocytosis driven by systemic delivery of IFN-␥ requires TLRs and NF-KB-dependent gene expression remains to be seen.
Animals from bony fish to humans accumulate hemophagocytes in response to severe infections caused by diverse microbes (7, 57) . These observations suggest that the process of hemophagocytosis has been conserved and may be of benefit to the host. We speculate that hemophagocytes contribute to the suppression of inflammation that is needed to recover from acute infection and are a mechanism of disease tolerance. Once under way, an inflammatory response has the potential to overwhelm and kill the host regardless of whether an invading pathogen is containable. Therefore, the suppression of inflammation is hardwired into the inflammatory response (58) , and hemophagocytosis may represent an additional mechanism of immunosuppression. Hemophagocytes express anti-inflammatory markers and produce the anti-inflammatory cytokine interleukin-10 (IL-10) (7, 49) . In addition, hemophagocytes may also contribute to tolerance via the breakdown of heme from erythrocytes, since both carbon monoxide and biliverdin have anti-inflammatory properties (59, 60) . In our cell culture system, we consistently observe that only a fraction (5 to 30%) of macrophages hemophagocytose under the conditions tested, suggesting that not all macrophages have this capability. Altogether, the data suggest that a subset of macrophages is triggered by TLR signaling to become hemophagocytes, cells that may contribute to the suppression of inflammation essential for recovery from immune mediated damage.
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